Announce Date | 08/05/2025 |
EPS Normalized Actual | $11.81 (Beat by $6.74) |
EPS GAAP Actual | $11.81 (Beat by $6.74) |
Revenue Actual | $1.2974B |
Revenue Surprise | Beat by $1297.4M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $6.254 |
EPS GAAP Estimate | $6.254 |
Revenue Estimate | $1.480925B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 27 | 14.55 | 26.02836 | 29.20464 | 2 |
Mar 2026 | 27.75 | 14.15 | 26.35044 | 28.72873 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 5.33 | 5.33 | 1.2974B | -5.26% | 1297.4M |
FQ1 2025 (Mar 2025) | 4.25 | 4.25 | 1.23328B | -3.68% | 1233.28M |
FQ4 2024 (Dec 2024) | 5.13 | 5.13 | 1.31221B | 1.99% | 1312.21M |
FQ2 2024 (Jun 2024) | 4.81 | 4.81 | 1.36561B | 3.54% | 1365.61M |
FQ3 2024 (Sep 2024) | 5.68 | 5.68 | 1.37327B | 3.43% | 1373.27M |
FQ4 2023 (Dec 2023) | 4.63 | 4.63 | 1.28607B | 1.67% | 1286.07M |
FQ1 2024 (Mar 2024) | 4.82 | 4.82 | 1.27872B | 1.05% | 1278.72M |
FQ3 2023 (Sep 2023) | 5.3 | 5.3 | 1.32612B | 1.89% | 1326.12M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
6.254
Consensus Revenue Estimates
1.480925B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.60523 | -- | 5.40077 | 5.76344 | 7 |
FQ3 2027 (Sep 2027) | 6.18116 | -- | 6.18116 | 6.18116 | 2 |
FQ2 2027 (Jun 2027) | 6.02404 | -- | 6.02404 | 6.02404 | 2 |
FQ1 2027 (Mar 2027) | 5.04211 | -- | 4.85819 | 5.18443 | 7 |
FQ4 2026 (Oct 2026) | 6.87 | -- | 6.58102 | 7.13613 | 1 |
FQ3 2026 (Jul 2026) | 5.75 | -- | 5.50813 | 5.97274 | 1 |
FQ2 2026 (Jun 2026) | 5.75 | 7.3 | 5.5964 | 5.91957 | 2 |
FQ1 2026 (Mar 2026) | 5.32 | 20.11 | 5.17788 | 5.47689 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.03B | -- | 1.97B | 2.07B | 8 |
FQ3 2027 (Sep 2027) | 2.14B | -- | 2.14B | 2.14B | 3 |
FQ2 2027 (Jun 2027) | 2.05B | -- | 2.05B | 2.05B | 3 |
FQ1 2027 (Mar 2027) | 1.77B | -- | 1.72B | 1.81B | 8 |
FQ4 2026 (Oct 2026) | 2.01B | -- | 1.94B | 2.07B | 2 |
FQ3 2026 (Jul 2026) | 1.92B | -- | 1.86B | 1.98B | 2 |
FQ2 2026 (Jun 2026) | 1.88B | 31.14 | 1.85B | 1.93B | 3 |
FQ1 2026 (Mar 2026) | 1.8B | 31.52 | 1.76B | 1.84B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 5.33 | 5.33 | 100% | |
FQ1 2025 (Mar 2025) | 4.25 | 4.25 | 100% | |
FQ4 2024 (Dec 2024) | 5.13 | 5.13 | 100% | |
FQ2 2024 (Jun 2024) | 4.81 | 4.81 | 100% | |
FQ3 2024 (Sep 2024) | 5.68 | 5.68 | 100% | |
FQ4 2023 (Dec 2023) | 4.63 | 4.63 | 100% | |
FQ1 2024 (Mar 2024) | 4.82 | 4.82 | 100% | |
FQ3 2023 (Sep 2023) | 5.3 | 5.3 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $1.3B | $1297.4M | 100% |
FQ1 2025 (Mar 2025) | $0B | $1.23B | $1233.28M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.31B | $1312.21M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.37B | $1365.61M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.37B | $1373.27M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.29B | $1286.07M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.28B | $1278.72M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.33B | $1326.12M | 100% |